Advanced

Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.

Xu, Ning LU ; Zhang, Xiao-Ying; Dong, Xuan; Ekström, Ulf LU ; Ye, Qing and Nilsson-Ehle, Peter LU (2002) In Biochemical and Biophysical Research Communications 292(4). p.944-950
Abstract
Apolipoprotein M (apoM) is a recently discovered human apolipoprotein predominantly present in high-density lipoprotein (HDL) in plasma, exclusively expressed in liver and in kidney. The function of apoM is yet unknown. The human apoM gene is located in the major histocompatibility complex class III region on chromosome 6. Because many genes located in this region are related to the immune response, we have investigated whether apoM might also be involved in the host inflammatory response. In this study we examined effects of the platelet-activating factor (PAF), tumor necrosis factor (TNF-alpha), and interleukin-1alpha (IL-1alpha) on apoM expression in a hepatoblastoma cell line, HepG2 cells. PAF significantly enhanced the apoM mRNA... (More)
Apolipoprotein M (apoM) is a recently discovered human apolipoprotein predominantly present in high-density lipoprotein (HDL) in plasma, exclusively expressed in liver and in kidney. The function of apoM is yet unknown. The human apoM gene is located in the major histocompatibility complex class III region on chromosome 6. Because many genes located in this region are related to the immune response, we have investigated whether apoM might also be involved in the host inflammatory response. In this study we examined effects of the platelet-activating factor (PAF), tumor necrosis factor (TNF-alpha), and interleukin-1alpha (IL-1alpha) on apoM expression in a hepatoblastoma cell line, HepG2 cells. PAF significantly enhanced the apoM mRNA levels and the secretion of apoM in HepG2 cell cultures. The enhancement of apoM secretion is seen at a low concentration of PAF (2 ng/ml), whereas a high concentration of PAF increases both the apoM mRNA levels and apoM secretion. Neither TNF-alpha nor IL-1alpha influenced apoM mRNA level and secretion. Furthermore, Lexipafant, a PAF-receptor (PAF-R) antagonist significantly suppressed the mRNA level and the secretion of apoM in HepG2 cells in a dose-dependent manner. Neither PAF nor Lexipafant influenced the mRNA levels and the secretion of apoA-I, apoB and apoE in HepG2 cells, indicating that the effects of PAF or Lexipafant on the apoM production on hepatic cells are selective for apoM. The cellular mechanism of the effects of PAF or Lexipafant on apoM metabolism requires further investigations. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Apolipoproteins B : metabolism, Apolipoproteins B : genetics, Apolipoproteins : metabolism, Apolipoproteins : genetics, Apolipoprotein A-I : metabolism, Apolipoprotein A-I : genetics, Interleukin-1 : pharmacology, Leucine : analogs & derivatives, Leucine : pharmacology, Liver Neoplasms : drug therapy, Tumor Necrosis Factor : pharmacology, Cultured, Tumor Cells, Non-U.S. Gov't, Support, Messenger : metabolism, RNA, Platelet Activating Factor : pharmacology, Liver Neoplasms : metabolism, Platelet Activating Factor : antagonists & inhibitors, Apolipoproteins E : genetics, Apolipoproteins E : metabolism, Dose-Response Relationship, Drug, Gene Expression : drug effects, Hepatoblastoma : drug therapy, Hepatoblastoma : metabolism, Human, Imidazoles : pharmacology
in
Biochemical and Biophysical Research Communications
volume
292
issue
4
pages
944 - 950
publisher
Elsevier
external identifiers
  • wos:000175171800025
  • pmid:11944906
  • scopus:0036293085
ISSN
1090-2104
DOI
10.1006/bbrc.2002.6755
language
English
LU publication?
yes
id
6d618442-0c2b-4352-af2a-c0fcaa4037c0 (old id 107581)
alternative location
http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11944906&dopt=Abstract
date added to LUP
2007-07-06 11:49:46
date last changed
2017-04-16 04:07:43
@article{6d618442-0c2b-4352-af2a-c0fcaa4037c0,
  abstract     = {Apolipoprotein M (apoM) is a recently discovered human apolipoprotein predominantly present in high-density lipoprotein (HDL) in plasma, exclusively expressed in liver and in kidney. The function of apoM is yet unknown. The human apoM gene is located in the major histocompatibility complex class III region on chromosome 6. Because many genes located in this region are related to the immune response, we have investigated whether apoM might also be involved in the host inflammatory response. In this study we examined effects of the platelet-activating factor (PAF), tumor necrosis factor (TNF-alpha), and interleukin-1alpha (IL-1alpha) on apoM expression in a hepatoblastoma cell line, HepG2 cells. PAF significantly enhanced the apoM mRNA levels and the secretion of apoM in HepG2 cell cultures. The enhancement of apoM secretion is seen at a low concentration of PAF (2 ng/ml), whereas a high concentration of PAF increases both the apoM mRNA levels and apoM secretion. Neither TNF-alpha nor IL-1alpha influenced apoM mRNA level and secretion. Furthermore, Lexipafant, a PAF-receptor (PAF-R) antagonist significantly suppressed the mRNA level and the secretion of apoM in HepG2 cells in a dose-dependent manner. Neither PAF nor Lexipafant influenced the mRNA levels and the secretion of apoA-I, apoB and apoE in HepG2 cells, indicating that the effects of PAF or Lexipafant on the apoM production on hepatic cells are selective for apoM. The cellular mechanism of the effects of PAF or Lexipafant on apoM metabolism requires further investigations.},
  author       = {Xu, Ning and Zhang, Xiao-Ying and Dong, Xuan and Ekström, Ulf and Ye, Qing and Nilsson-Ehle, Peter},
  issn         = {1090-2104},
  keyword      = {Apolipoproteins B : metabolism,Apolipoproteins B : genetics,Apolipoproteins : metabolism,Apolipoproteins : genetics,Apolipoprotein A-I : metabolism,Apolipoprotein A-I : genetics,Interleukin-1 : pharmacology,Leucine : analogs & derivatives,Leucine : pharmacology,Liver Neoplasms : drug therapy,Tumor Necrosis Factor : pharmacology,Cultured,Tumor Cells,Non-U.S. Gov't,Support,Messenger : metabolism,RNA,Platelet Activating Factor : pharmacology,Liver Neoplasms : metabolism,Platelet Activating Factor : antagonists & inhibitors,Apolipoproteins E : genetics,Apolipoproteins E : metabolism,Dose-Response Relationship,Drug,Gene Expression : drug effects,Hepatoblastoma : drug therapy,Hepatoblastoma : metabolism,Human,Imidazoles : pharmacology},
  language     = {eng},
  number       = {4},
  pages        = {944--950},
  publisher    = {Elsevier},
  series       = {Biochemical and Biophysical Research Communications},
  title        = {Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.},
  url          = {http://dx.doi.org/10.1006/bbrc.2002.6755},
  volume       = {292},
  year         = {2002},
}